Mr Thomas Boon Leong Lam

Mr. Thomas Lam graduated from Leeds University School of Medicine in 1997 and completed his basic surgical training in 2001. He obtained his PhD in surgical oncology, and completed his higher surgical training in urology in Aberdeen and Edinburgh in 2011. He was appointed consultant urological surgeon and senior lecturer in October 2011. He has a sub-specialist interest in prostate cancer and robotic radical prostatectomy, urinary tract infections, painful bladder syndrome, urodynamic studies, Botox injections and benign prostatic enlargement. Academically, his main areas of interest include clinical trials, evidence-based medicine, evidence synthesis and meta-analysis, clinical practice guideline development, core outcome sets in urological conditions, and methods research. His research grant income is in excess of £7 million, with the majority of his projects being funded by the UK NIHR HTA Programme and the European Association of Urology Guidelines Office. He has published extensively in his areas of interest, having authored more than 250 peer-reviewed publications. He is heavily involved in the development and production of European Association of Urology Clinical Practice Guidelines which issues guidelines to urologists around the world, being a member of the EAU Prostate Cancer Guideline Panel and the EAU Renal Cell Cancer Guideline Panel. He also has a strong track record in undergraduate and postgraduate training and education, being an educational supervisor for medical students, FY2 and CT doctors, and supervisor for PhD and MD students.

My sub-specialist areas of interest include the diagnosis and management of localised prostate cancer, robotic radical prostatectomy, urinary tract infections, painful bladder syndrome (interstitial cystitis), urodynamic studies, intradetrusor Botox injections for overactive bladder syndrome, and benign prostatic enlargement.